No Mutation Needed: New Treatments Being Developed for a Small Group of Parkinson’s Patients May Work for Most People with the Disease

Pitt, The Pittsburgh Institute for Neurodegenerative Diseases (PIND) , and UPMC are performing impactful work in the world of neurodegeneration and Parkinson’s Disease. Please follow the link below to read more about the latest research published by Dr. J. Timothy Greenamyre and his team within the PIND.


Posted in: